A Gender-Dependent Molecular Switch of Inflammation via MyD88/Estrogen Receptor-Alpha Interaction
Rana El Sabeh,Mélanie Bonnet,Katy Le Corf,Kevin Lang,Alain Kfoury,Bassam Badran,Nader Hussein,Francois Virard,Isabelle Treilleux,Muriel Le Romancer,Serge Lebecque,Serge Manie,Isabelle Coste,Toufic Renno
DOI: https://doi.org/10.2147/JIR.S306805
IF: 4.5
2021-05-22
Journal of Inflammation Research
Abstract:Rana El Sabeh, 1, 2 Mélanie Bonnet, 1 Katy Le Corf, 1 Kevin Lang, 1 Alain Kfoury, 1 Bassam Badran, 2 Nader Hussein, 2 Francois Virard, 1 Isabelle Treilleux, 3 Muriel Le Romancer, 1 Serge Lebecque, 1 Serge Manie, 1 Isabelle Coste, 1, * Toufic Renno 1, * 1 Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France; 2 Université Libanaise, PRASE, Hadath, Lebanon; 3 Pathology Department, Centre Léon Bérard, Lyon, France *These authors contributed equally to this work Correspondence: Toufic Renno; Isabelle Coste Centre de Recherche en Cancétologie de Lyon, 28 Rue Laennec, Lyon, 69373, France Tel +33 4 691 666 29; +33 4 691 666 30 Email ; Introduction: Most Toll-like receptors and IL-1/IL-18 receptors activate a signaling cascade via the adaptor molecule MyD88, resulting in NF-κB activation and inflammatory cytokine and chemokine production. Females are less susceptible than males to inflammatory conditions, presumably due to protection by estrogen. The exact mechanism underlying this protection is unknown. Methods: MCF7 cells expressing wild-type or mutated LXXLL motif were used to determine MyD88/estrogen receptor (ER)-a interaction by immunoprecipitation and cell activation by ELISA and luciferase reporter assay. IL-1b and/or E2 were used to activate MCF7 cells expressing normal or knocked down levels of PRMT1. Finally, in situ proximity ligation assay with anti-MyD88 and anti-methylated ER-a (methER-a) antibodies was used to evaluate MyD88/methylated ER-a interaction in THP1 cells and histological sections. Results: We show that MyD88 interacts with a methylated, cytoplasmic form of estrogen receptor-alpha (methER-α). This interaction is required for NF-κB transcriptional activity and pro-inflammatory cytokine production, and is dissociated by estrogen. Importantly, we show a strong gender segregation in gametogenic reproductive organs, with MyD88/methER-α interactions found in testicular tissues and in ovarian tissues from menopausal women, but not in ovaries from women age 49 and less – suggesting a role for estrogen in disrupting this complex in situ. Discussion: Collectively, our results indicate that the formation of MyD88/methER-α complexes during inflammatory signaling and their disruption by estrogen may represent a mechanism that contributes to gender bias in inflammatory responses. Keywords: nuclear receptor, post-translational modification, inflammation, protein-protein-interaction Females are relatively protected from certain diseases with an underlying inflammatory component, such as atherosclerosis, 1 ischemic stroke, 2 adipocyte atrophy, 3 blood-brain barrier disruption, 4 LPS-induced endotoxic shock, 5 colitis, 6 and cancers that develop on an inflammatory background, such as hepatocellular carcinoma (HCC). 7 The relative protection from inflammation is thought to be mainly due to the high levels of estrogen in pre-menopaused women. 8 , 9 Menopaused or ovariectomized females have increased inflammation, whereas estrogen-treated males had milder inflammatory responses. 10 Estrogen is produced both in males and females, but at much higher levels in the latter until menopause. Estrogen has been shown to be an inhibitor of inflammation, mainly via decreasing NF-kB signaling, leading to decreased cytokine and chemokine production. 11 It was reported that MyD88-dependent activation of interleukin-6 is negatively regulated by estrogen via the estrogen receptor alpha (ER-α). 12 MyD88 is the main adaptor protein in TLR and IL-1R signaling that induces the activation of NF-kB. 13 Here we describe a novel mechanism of inflammatory signaling regulation via the interaction between MyD88 and a cytoplasmic form of ER-α, with implications for gender disparity in inflammatory responses. The MCF7 and THP1cell lines were purchased from ATCC. After treatment, cells were lysed using NP-40 lysis buffer supplemented with protease and phosphatase inhibitors. Protein extracts (1mg) were incubated with primary antibody G20 from Santa Cruz (overexpressed ER-α) or antibody specific to endogenous methER-α. <a href= -Abstract Truncated-
immunology